384 related articles for article (PubMed ID: 11268287)
21. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
Shi CX; Hitt M; Ng P; Graham FL
Hum Gene Ther; 2002 Jan; 13(2):211-24. PubMed ID: 11812278
[TBL] [Abstract][Full Text] [Related]
22. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
Pang S; Taneja S; Dardashti K; Cohan P; Kaboo R; Sokoloff M; Tso CL; Dekernion JB; Belldegrun AS
Hum Gene Ther; 1995 Nov; 6(11):1417-26. PubMed ID: 8573614
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors.
Jiang S; Altmann A; Grimm D; Kleinschmidt JA; Schilling T; Germann C; Haberkorn U
Cancer Gene Ther; 2001 Jul; 8(7):469-72. PubMed ID: 11498767
[TBL] [Abstract][Full Text] [Related]
24. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
25. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
Zeng H; Liao YC; Wang F; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):782-5. PubMed ID: 16334552
[TBL] [Abstract][Full Text] [Related]
26. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
[TBL] [Abstract][Full Text] [Related]
27. Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein.
Shan JD; Porvari K; Ruokonen M; Karhu A; Launonen V; Hedberg P; Oikarinen J; Vihko P
Endocrinology; 1997 Sep; 138(9):3764-70. PubMed ID: 9275063
[TBL] [Abstract][Full Text] [Related]
28. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.
Yoshimura I; Ikegami S; Suzuki S; Tadakuma T; Hayakawa M
J Urol; 2002 Dec; 168(6):2659-64. PubMed ID: 12442005
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
31. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
32. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells.
Borrelli MJ; Schoenherr DM; Wong A; Bernock LJ; Corry PM
Cancer Res; 2001 Feb; 61(3):1113-21. PubMed ID: 11221841
[TBL] [Abstract][Full Text] [Related]
33. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
Chapel-Fernandes S; Jordier F; Lauro F; Maitland N; Chiaroni J; de Micco P; Mannoni P; Bagnis C
Cancer Gene Ther; 2006 Oct; 13(10):919-29. PubMed ID: 16741521
[TBL] [Abstract][Full Text] [Related]
34. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
35. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
36. Evidence of the capability of the CMV enhancer to activate in trans gene expression in mammalian cells.
D'Aiuto L; De Marco R; Edward N; Rizzo A; Chaillet JR; Montecalvo A; Lotze MT; Gambotto A
DNA Cell Biol; 2006 Mar; 25(3):171-80. PubMed ID: 16569196
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
[TBL] [Abstract][Full Text] [Related]
38. Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy.
Ribault S; Neuville P; Méchine-Neuville A; Augé F; Parlakian A; Gabbiani G; Paulin D; Calenda V
Circ Res; 2001 Mar; 88(5):468-75. PubMed ID: 11249869
[TBL] [Abstract][Full Text] [Related]
39. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
[TBL] [Abstract][Full Text] [Related]
40. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
